Dr. Tay Lik Wui Edgar‎

1. General Cardiology
2. Cardiac imaging ( Echocardiography and CT coronary angiography)
3. Stress testing
4. Coronary angiogram and PCI

1. Transcatheter aortic valve implantation and replacement
2. Mitral transcatheter therapy ( eg. Mitraclip)
3. Tricuspid transcatheter therapy ( eg TRiclip)
4. Transcatheter pulmonary valve replacement and therapy ( eg melody valve)
5. Congenital heart interventions ( Closure of atrial septal defects, patent ductus arteriosus, pulmonary valve and aortic valve valvuloplasty
6. Closure of left atrial appendage (eg watchman)
7. Closure of PFO for stroke prevention
8. Right heart catheter study and pulmonary hypertension treatment
9. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Dr Edgar Tay graduated with Bachelor of Medicine and Surgery from the National University of Singapore and was admitted as Member of the Royal College of Physicians (United Kingdom). He completed Advanced Specialist Training (Cardiology) at the National University Heart Centre Singapore (NUHCS).

Dr Tay was then awarded the prestigious 2-year Ministry of Health Scholarship to pursue further structural heart disease training: He spent 1 year at the world renowned Royal Brompton Hospital (London, UK) in adult congenital heart disease and pulmonary hypertension. Following this, he underwent further training in interventional cardiology focusing on transcatheter valve interventions (TAVI) at St Paul’s Hospital, Vancouver, Canada.

Dr Tay was formerly a Senior Consultant and the Director of the Structural Heart Disease Programme at the National University Heart Centre of Singapore. He is also an Assistant Professor at the Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore. During his work in NUHCS, he started the Transcatheter Aortic Valve Implantation (TAVI) programme, Mitraclip Mitral Valve Repair programme, Percutaneous Pulmonary Valve Implantation Programme and the Balloon Pulmonary Angioplasty programme for Chronic Thromboembolic Pulmonary hypertension. He was awarded the National Medical Excellence Team Award in 2011

He actively teaches and was the Associate Programme Director for the Cardiology Senior Residency Programme in NUHCS, as well as a Member of the Cardiology Resident Advisory Committee. He has also mentored and trained several post-doctoral students and fellows and helped proctor several overseas physicians in their transcatheter heart valve programmes. He was also invited to share cardiac treatment techniques via satellite transmission to international sites in US, Europe and Asia.

Dr Tay is also very active in research and was awarded national grants related to heart treatment innovations. In addition, Dr Tay has authored several book chapters and many peer-reviewed research articles and won the Young Investigator Award in 2015. He has been an invited faculty and scientific committee member for multiple international interventional cardiology symposia.

During his time in public service, Dr Tay was also Director of Clinical Services ( Cardiology) at the AH Campus NUHCS. He served as the Department Patient Safety Officer in NUH and pioneered several safety initiatives. He had also participated in humanitarian outreach programmes to help patients overseas with heart valve disease and was conferred the Fung Foundation Fellowship. He is also the current medical advisor to the Pulmonary Hypertension Association of Singapore. Dr Tay has also been involved in several cardiology leadership positions including being in the Executive Council of the Singapore Cardiac Society, membership in the Singapore Chapter of cardiology and is also the current Governor of the Singapore Chapter of the American College of Cardiology.

1. Tay E, Paul B, Sharp J, et al. Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region. J Interv Card Electrophysiol. 2021 Aug;61(2):269-281
2. Tay E, Khaing T, Yin WH, et al. Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registry. AsiaIntervention. 2021 Jul;7(1):54-59.
3. Tay EL, Hayashida K, Chen M, et al. Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia. J Card Surg. 2020 Sep;35(9):2142-2146.
4. Sazzad F, Ler AAL, Furqan MS, Tan LKZ, Leo HL, Kuntjoro I, Tay E, Kofidis T. Harnessing the power of artificial intelligence in predicting all-cause mortality in transcatheter aortic valve replacement: a systematic review and meta-analysis. Front Cardiovasc Med. 2024 May 31;11:1343210.
5. Armario X, Carron J, Simpkin AJ et al. The COVID-TAVI Study. JACC Cardiovasc Interv. 2024 Feb 12;17(3):374-387.
6. Dimopoulos K, Constantine A, Clift P et al. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus. Circulation. 2023 Jan 31;147(5):425-441.
7. Butcher SC, Prevedello F, Fortuni F et al. Prevalence and Prognostic Implications of Moderate or Severe Mitral Regurgitation in Patients with Bicuspid Aortic Valve. J Am Soc Echocardiogr. 2023 Apr;36(4):402-410.
8. Hecht S, Butcher SC, Pio SM et al. Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease. J Am Coll Cardiol. 2022 Sep 13;80(11):1071-1084.
9. Lim Y, Tan KA, Kuntjoro I et al. Coronary Artery Disease in Patients Undergoing Transvalvular Aortic Valve Implantation. Interv Cardiol. 2022 Sep 29;17:e13.
10. Xiong TY, Ali WB, Feng Yet al.Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization. Nat Rev Cardiol. 2023 Jan;20(1):52-67.
11. Ng P, Cherian R, Chan SP et al. Severe Functional Tricuspid Valve Regurgitation: Predictors of Mortality After Initial Diagnosis. Heart Lung Circ. 2022 Sep;31(9):1234-1240.

• Awarded Dean’s list 1995,1996,1997,1998
• Ministry of Heath Scholarship (2008-2010)

• Singapore Cardiac Society Treasurer ( 2014-2016)
• Singapore Cardiac Society Elected Member (2016- 2020)
• Chapter of Cardiologist Ex Board Member
• Pulmonary Hypertension Singapore: Medical Advisor
• International CTEPH Association: Member
• Governor of the Singapore Chapter of the American College of Cardiology
• Advisor to Singapore Pulmonary Hypertension Society